850040-08-3

Basic information

• Product Name: ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate
• Synonyms: ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate;4-Piperidinecarboxylic acid,3-hydroxy-1-(phenylmethyl)-,ethyl ester
• CAS NO: 850040-08-3
• Molecular Formula: C₁₅H₂₁NO₃
• Molecular Weight: 263.33214
• Mol File: 850040-08-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate(850040-08-3)
• EPA Substance Registry System: ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate(850040-08-3)

Safety Data

• Hazardous Substances Data: 850040-08-3(Hazardous Substances Data)

Usage

General Description

Ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate is a chemical compound with the molecular formula C18H23NO3. It is a derivative of piperidine, a heterocyclic organic compound. This chemical is commonly used in research and pharmaceutical applications, particularly in the development of new drugs and medications. It can also be used as a building block in organic synthesis to create other related compounds. Its structure includes a piperidine ring with a benzyl group and a carboxylate ester functional group, which are important for its biological and chemical properties. Overall, ethyl 1-benzyl-3-hydroxypiperidine-4-carboxylate is an important chemical with potential applications in various fields including medicine, research, and industry.

Upstream product

• 52763-21-0 ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride 
• 39514-19-7 ethyl 1-benzyl-3-oxo-4-piperidinecarboxylate 

Relevant articles and documents

Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as ROR?3t Allosteric Inhibitors for Autoimmune Diseases

The clinical success of anti-IL-17 monoclonal antibodies (i.e., Cosentyx and Taltz) has validated Th17 pathway modulation for the treatment of autoimmune diseases. The nuclear hormone receptor RORγt is a master regulator of Th17 cells and affects the prod

3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

Novel amides useful for treating pain

The present invention relates to compounds of formula (I-VII) or a pharmaceutically acceptable salt or prodrug thereof, in which A, L, R6, R7 and R8 are defined herein. The present invention also relates to methods of trating pain using these compounds and pharmaceutical compositions including these compounds.